Skip to main content
Clinical Trials/ACTRN12622000526774
ACTRN12622000526774
Recruiting
未知

Efficacy of repeated low-level red-light therapy in myopia control in schoolchildren: a randomized controlled trial

Eyerising International Pty Ltd0 sites108 target enrollmentApril 4, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Eyerising International Pty Ltd
Enrollment
108
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 4, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Eyerising International Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\) Provision of consent
  • 2\) Age: \>\=8 and \<\= 13 years at enrolment
  • 3\) Myopia: Spherical equivalent refractions (SERs) under cycloplegia: \-1\.00 to \-5\.00 diopters (D)
  • 4\) Astigmatism of 2\.50 D or less
  • 5\) Anisometropia of 1\.50 D or less
  • 6\) Corrected monocular logMAR visual acuity (VA): 1\.0 or better
  • 7\) Consent to participate in random allocation of grouping
  • 8\) Fluent in English
  • 9\) Willing and able to participate in all required activities of the study

Exclusion Criteria

  • 1\) Strabismus and binocular vision abnormalities in either eye
  • 2\) Ocular abnormalities in either eye or other systemic abnormalities that affect participate in all required activities of the study.
  • 3\) Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc.
  • 4\) Other reasons, including but not limited to severe physical and cognitive disability, that the physician may consider inappropriate for enrolment
  • 5\) Noncompliance with treatment
  • 6\) Children whose parents do not sign informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials